Insider trades
MPM Oncology Innovations Fund, 10% Owner of Aktis Oncology AKTS, has filed 1 purchase and 29 sales on the open market. Over the past 12 months that comes to a net purchase of $17.8M. The latest trade was on 01/12.
MPM Oncology Innovations Fund
10% Owner
- Company
- Aktis Oncology AKTS
- First filing
- 25/04/30
- Trades
- 39 trades
- Buys / sales
- 1 / 29
- 12-month net buying
- $17.8M
- Last trade
- 01/12
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
Aktis OncologyAKTS | Open-market buy | 01/12 | 01/14 | 1,112,777 sh | $18.00 | $20,029,986 | +12.2% |
HOWL | Open-market sale10b5-1 plan | 25/12/02–25/12/04 | 25/12/04 | 199,732 sh3 trades | $0.92avg. | $183,275.38 | −4.0% |
HOWL | Open-market sale10b5-1 plan | 25/11/26–25/12/01 | 25/12/01 | 141,927 sh3 trades | $0.96avg. | $136,854.55 | −2.8% |
HOWL | Open-market sale10b5-1 plan | 25/11/21–25/11/25 | 25/11/25 | 195,666 sh3 trades | $0.92avg. | $179,551.05 | −3.7% |
HOWL | Open-market sale10b5-1 plan | 25/11/18–25/11/20 | 25/11/20 | 160,103 sh3 trades | $0.92avg. | $147,912.95 | −2.9% |
HOWL | Open-market sale10b5-1 plan | 25/11/13–25/11/17 | 25/11/17 | 209,652 sh3 trades | $0.96avg. | $200,665.13 | −3.7% |
HOWL | Open-market sale10b5-1 plan | 25/11/07–25/11/12 | 25/11/12 | 213,529 sh4 trades | $1.13avg. | $241,278.01 | −3.6% |
HOWL | Open-market sale10b5-1 plan | 25/11/04–25/11/06 | 25/11/06 | 242,890 sh3 trades | $1.22avg. | $295,781.28 | −4.0% |
HOWL | Open-market sale10b5-1 plan | 25/10/30–25/11/03 | 25/11/03 | 295,043 sh3 trades | $1.33avg. | $391,636.07 | −4.6% |
HOWL | Open-market sale10b5-1 plan | 25/10/27–25/10/29 | 25/10/29 | 276,017 sh3 trades | $1.62avg. | $446,403 | −4.1% |
| Open-market sale | 25/03/27 | 25/04/30 | 4,386 sh | $1.05 | $4,605.3 | −0.1% |
